Venous Thromboembolism in Aggressive B‐Cell Lymphoma Patients Treated with CD19 CAR‐T Therapy: Single‐Institution Study
LBCL patients receiving CAR-T therapy have a significant risk of VTE, particularly within the first month and among those with PMBCL and high-grade ICANS. This highlights the need to study the role of venous thromboprophylaxis in this context.
Authors
- Kevin J. Milligan (ORCID: https://orcid.org/0000-0003-2560-5738)
- Ryan Sun (ORCID: https://orcid.org/0000-0003-1176-1561)
- Jeremy Ramdial (ORCID: https://orcid.org/0000-0002-8984-3420)
- Amy A. Ayers (ORCID: https://orcid.org/0000-0003-4807-2356)
- Julia Parrish
- Neha Venkatesh
- C. Pérez Hernández
- Yun Qing
- Paolo Strati
- Sairah Ahmed
Institutions
- The University of Texas MD Anderson Cancer Center (US)
- Baylor College of Medicine (US)
Publication Details
- Journal
- eJHaem
- Published
- 2026-01-30
- DOI
- https://doi.org/10.1002/jha2.70227
- Primary Topic
- CAR-T cell therapy research
- Type
- article
- Field-Weighted Citation Impact
- 0.00